Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan-Dec:32:10732748251343245.
doi: 10.1177/10732748251343245. Epub 2025 May 23.

Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer

Affiliations

Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer

Enes Erul et al. Cancer Control. 2025 Jan-Dec.

Abstract

IntroductionThe use of artificial intelligence (AI) in oncology has increased rapidly, transforming various healthcare areas such as pathology, radiology, diagnostics, prognosis, genomics, treatment planning, and clinical trials. However, perspectives, comfort levels, and concerns about AI in cancer care remain largely unexplored.Materials and MethodsThis prospective, descriptive cross-sectional survey study was conducted between May 20, 2024 and October 22, 2024, among 363 patients with cancer from two different hospitals affiliated with Ankara University, a tertiary care center in Türkiye. The survey included three distinct sections: (1) Perceptions: Patients' general views on AI's impact in oncology; (2) Attitudes: Comfort level with AI performing medical tasks; (3) Concerns: Specific fears related to AI implementation (eg, diagnostic errors, data privacy, healthcare costs). Survey responses were summarized descriptively, and differences by age, gender, and education were analyzed using chi-square tests.ResultsA majority (50.7%) believed AI would somewhat (32%) or significantly (18.7%) improve healthcare. However, one-third of patients (33.1%) were very uncomfortable with AI diagnosing cancer, with higher discomfort among less-educated participants (P < .005). Top patient concerns included AI making incorrect diagnoses (31.1%), increasing healthcare costs (27.5%), and not keeping data private (19.6%). Patients with higher education levels expressed less discomfort and fewer concerns.ConclusionsPatients' perceptions and attitudes on AI varied significantly based on education, highlighting the need for targeted educational initiatives. While AI holds potential to revolutionize cancer care, addressing concerns about accuracy, security, and transparency is critical to enhance its acceptance and effectiveness in clinical practice.

Keywords: artificial intelligence; cancer care; chatbots; comfort levels; healthcare concerns; machine learning and deep learning systems; natural language processing; patient perspectives.

Plain language summary

Artificial intelligence (AI) is becoming an important tool in cancer care, assisting in diagnosis, treatment planning, and clinical decision-making. However, not all patients feel comfortable with AI being used in their medical care. This study surveyed 363 cancer patients to understand their perspectives on AI in oncology. Findings revealed that while many patients believe AI can improve healthcare, others have concerns about diagnostic accuracy, data privacy, and the economic impact of AI-driven medical decisions. Patients with higher education levels showed greater acceptance of AI. To ensure that AI is effectively integrated into oncology, policymakers and healthcare professionals must address these concerns, enhance patient education, and establish ethical guidelines for AI applications in medicine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Illustrates the Three Distinct Measurement Scales Used in the Survey. The Perception Scale Assesses Patients’ General Views on AI’s Impact in Oncology, the Comfort Scale Evaluates Their Emotional Response and Willingness to Accept AI in Clinical Practice, and the Concern Scale Measures Specific Fears Related to AI Adoption, Such as Misdiagnosis and Privacy Issues.
Figure 2.
Figure 2.
Proportions of the Answers for 90% and 98% Model Accuracy.
Figure 3.
Figure 3.
Illustrates the Concerns of Cancer Patients Regarding the Use of Artificial Intelligence in Cancer Care.
Figure 4.
Figure 4.
Correlation Matrix Illustrating the Relationships Between Perception, Comfort, and Concern Scores Among Oncology Patients.
Figure 5.
Figure 5.
Using Our Causal Graph, we Estimate a Linear Regression Model to Examine the Effects of Education to Comforts and Concerns of AI in Healthcare by Factoring the Confounding Variables and excluding the Mediator.
Figure 6.
Figure 6.
Within-cluster sum of squares (WCSS) for different cluster numbers.
Figure 7.
Figure 7.
Cluster Visualization Based on Concern and Comfort Scores.
Figure 8.
Figure 8.
Distribution of Concern-Comfort Clusters Across Education and Age Categories. (A) Cluster Proportions by Educational Background. (B) Cluster Proportions by Age Group.

Similar articles

References

    1. Khullar D, Casalino LP, Qian Y, Lu Y, Chang E, Aneja S. Public vs physician views of liability for artificial intelligence in health care. J Am Med Inform Assoc. 2021;28(7):1574-1577. - PMC - PubMed
    1. Ming C, Viassolo V, Probst-Hensch N, Dinov ID, Chappuis PO, Katapodi MC. Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations. Br J Cancer. 2020;123(5):860-867. - PMC - PubMed
    1. Bibault JE, Bassenne M, Ren H, Xing L. Deep learning prediction of cancer prevalence from satellite Imagery. Cancers (Basel). 2020;12(12):3844. - PMC - PubMed
    1. Nitta S, Tsutsumi M, Sakka S, et al. Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity. Prostate Int. 2019;7(3):114-118. - PMC - PubMed
    1. Han SS, Kim YJ, Moon IJ, et al. Evaluation of artificial intelligence–assisted diagnosis of skin neoplasms: a single-center, paralleled, unmasked, randomized controlled trial. J Invest Dermatol. 2022;142(9):2353-2362.e2352. - PubMed

LinkOut - more resources